Enzo Biochem, Inc. (NYSE:ENZ)

CAPS Rating: 2 out of 5

The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community.

Recs

1
Player Avatar trm3 (36.56) Submitted: 9/10/2008 2:54:17 PM : Outperform Start Price: $11.23 ENZ Score: -92.08

pwr 10

Featured Broker Partners


Advertisement